Search Results for

*

1-18 of 18 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Abaloparatide (Tymlos) for Osteoporosis - STEPS - American Family Physician

Feb 15, 2019 - Abaloparatide is a safe and effective medication used to reduce the likelihood of vertebral and nonvertebral fractures in women at high risk. However, it is expensive and requires daily injections. It has not been evaluated for its effect on decreasing hip fractures.

American Family Physician : STEPS

https://www.aafp.org/afp/2019/0215/p260.html

ACOG Releases Guidelines for Clinical Management of Osteoporosis - Practice Guidelines ...

Mar 15, 2004 - The American College of Obstetricians and Gynecologists (ACOG) recently issued guidelines for the clinical management of osteoporosis in women, including recommendations for screening, prevention, and treatment.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2004/0315/p1558.html

ACP Releases Guideline on Treatment of Low Bone Mineral Density or Osteoporosis to ...

May 1, 2009 - The American College of Physicians (ACP) recently released guidelines on treatment of low bone mineral density (BMD) or osteoporosis to prevent fractures describes the available evidence on pharmacologic treatment in men and women.

American Family Physician : Practice Guidelines

https://www.aafp.org/afp/2009/0501/p808.html

Alendronate for Fracture Prevention in Postmenopause - Cochrane for Clinicians - ...

Sep 1, 2008 - In postmenopausal women, a 10-mg daily dose of alendronate is effective for secondary (number needed to treat [NNT] = 16) and primary (NNT = 50) prevention of vertebral fractures. It is also effective for secondary prevention of nonvertebral fractures, including hip or wrist fractures ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2008/0901/p579.html

Bone Density Testing to Monitor Osteoporosis Therapy in Clinical Practice - Editorials:...

Oct 1, 2010 - The bottom line in caring for patients with osteoporosis is that monitoring for treatment effect is appropriate and desirable. A statistically significant BMD loss may lead to further evaluation and possibly a change in treatment. The strategy of monitoring therapy with BMD testing is ...

American Family Physician : Editorials: Controversies in Family Medicine

https://www.aafp.org/afp/2010/1001/p749.html

Combination Therapy for Postmenopausal Osteoporosis - FPIN's Clinical Inquiries - ...

Feb 15, 2010 - There is insufficient evidence to recommend combination therapy for the routine management of postmenopausal osteoporosis.

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2010/0215/p439.html

Denosumab (Prolia) for Treatment of Postmenopausal Osteoporosis - STEPS - American ...

Feb 15, 2012 - Prolia is an expensive method of preventing osteoporotic hip fractures, and is associated with significant adverse effects. Safer, less expensive options exist for preventing fracture in high-risk women.

American Family Physician : STEPS

https://www.aafp.org/afp/2012/0215/p334.html

Denosumab for Reducing Risk of Fractures in Postmenopausal Women - Medicine by the ...

May 1, 2019 - Denosumab appears to be effective in reducing the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Treatment with denosumab does not increase the risk of cancer or death but might increase the risk of infection. However, more studies are required.

American Family Physician : Medicine by the Numbers

https://www.aafp.org/afp/2019/0501/od1.html

Duration of Bisphosphonate Therapy - FPIN's Help Desk Answers - American Family Physician

Apr 1, 2018 - Oral bisphosphonates significantly reduce clinical fracture risk at four years in women with postmenopausal osteoporosis (T-score less than −2.5). Treatment beyond five years is associated with further reductions in fractures in women with persistent femoral neck T-scores less than −2.5.

American Family Physician : FPIN's Help Desk Answers

https://www.aafp.org/afp/2018/0401/od1.html

Fracture Prevention in Postmenopausal Women - Clinical Evidence Handbook - American ...

May 15, 2008 - What are the effects of treatments to prevent fractures in postmenopausal women?

American Family Physician : Clinical Evidence Handbook

https://www.aafp.org/afp/2008/0515/p1447.html

Ibandronate (Boniva) for Treatment and Prevention of Osteoporosis in Postmenopausal ...

Jan 15, 2006 - Ibandronate is a bisphosphonate that can be taken daily or monthly. The daily dosage has been shown to decrease vertebral fractures in women with osteoporosis and a history of previous vertebral fractures. Neither formulation has been shown to reduce the risk of hip fracture or other ...

American Family Physician : STEPS

https://www.aafp.org/afp/2006/0115/p305.html

Osteoporosis Management: Out of Subspecialty Practice and into Primary Care - ...

Oct 1, 2004 - Advertisement << Previous article Next article >> Oct 1, 2004 Issue Editorials Osteoporosis Management: Out of Subspecialty Practice and into Primary Care MARGARET GOURLAY, M.D., M.P.H., University of North Carolina at Chapel Hill, Department of Family Medicine, Chapel Hill, North...

American Family Physician : Editorials

https://www.aafp.org/afp/2004/1001/p1219.html

Pharmacologic Prevention of Osteoporotic Fractures - American Family Physician

Oct 1, 2004 - Osteoporosis is characterized by low bone mineral density and a deterioration in the microarchitecture of bone that increases its susceptibility to fracture. The World Health Organization defines osteoporosis as a bone mineral density that is 2.5 standard deviations or more below the ...

American Family Physician : Article

https://www.aafp.org/afp/2004/1001/p1293.html

Risks of Bisphosphonate Use - FPIN's Clinical Inquiries - American Family Physician

Nov 15, 2013 - Bisphosphonates are associated with a small risk of atypical femoral shaft fractures, which increases with duration of use. Bisphosphonates are associated with a small risk of osteonecrosis of the jaw, which is more common in patients who are older, female, or have poor dental hygiene ...

American Family Physician : FPIN's Clinical Inquiries

https://www.aafp.org/afp/2013/1115/p697.html

Teriparatide (Forteo) for Osteoporosis - STEPS - American Family Physician

Apr 15, 2004 - Teriparatide increases bone density in men and women with osteoporosis and has reduced the risk of new vertebral fractures in high-risk women. Its role in therapy is not clear. Due to its uncertain safety profile, lack of long-term experience, and high cost, it makes sense to reserve ...

American Family Physician : STEPS

https://www.aafp.org/afp/2004/0415/p1983.html

The Female Athlete Triad: Recommendations for Management - Editorials - American Family...

Apr 15, 2018 - Family physicians should be familiar with recommendations regarding the female athlete triad, because prevention and early intervention can significantly reduce morbidity from this disorder.

American Family Physician : Editorials

https://www.aafp.org/afp/2018/0415/p499.html

Treating Low Vitamin D Levels Is Ineffective in Postmenopausal Women - POEMs - American...

Feb 15, 2016 - You do not have to treat a low vitamin D level if your patient is a typical community-dwelling postmenopausal woman younger than 75 years. The usual dosage of vitamin D, 800 IU (20 mcg) daily, will not increase levels even after a year of therapy and has little effect on calcium ...

American Family Physician : POEMs

https://www.aafp.org/afp/2016/0215/p315.html

Zoledronic Acid (Reclast) for Osteoporosis - STEPS - American Family Physician

Aug 15, 2008 - Zoledronic acid, in combination with calcium and vitamin D, will reduce the risk of vertebral fractures, and to a lesser extent, hip fractures in women with osteoporosis. It decreases subsequent fractures and mortality in high-risk patients who have had a hip fracture. Zoledronic acid ...

American Family Physician : STEPS

https://www.aafp.org/afp/2008/0815/p508.html

Page  1

25 50 100 results per page